CIMNA, the unique center for Immune monitoring. CRO / Central Lab / Services in Cytometry, ELISpot, Luminex, Miccroarrays, biostatistics, clinical management, medical writing...
CIMNA is an immunology service center that offers immune response analysis to support drug development. It provides expertise, state-of-the-art technologies, and quality services through specialized immunology testing including flow cytometry, ELISPOT, bead arrays, and transcriptomics. CIMNA has over 60 employees working in a 1300 square meter facility in Nantes, France, and is overseen by a scientific committee of experts in immunology and therapeutic areas.
2011 course on Molecular Diagnostic Automation - Part 3 - DetectionPatrick Merel
2011 course on Molecular Diagnostic Automation - Part 3 - Detection.
This is from early 2011. Prices and Specifications of instruments may have changed a lot.
Part 3 of 3
Microbial S.L. is a biotechnological company devoted to the design and production of products for the rapid detection of pathogen microorganisms in environmental and food samples.
2011 course on Molecular Diagnostic Automation - Part 2 - AmplificationPatrick Merel
2011 course on Molecular Diagnostic Automation - Part 2 - Amplification.
This is from early 2011. Prices and Specifications of instruments may have changed.
Part 2 of 3
The document discusses immune monitoring in vaccine trials. It provides context on regulatory requirements and the need for standardization. A variety of assays are used to assess cellular and antibody responses, including ELISPOT, flow cytometry, and neutralizing antibody assays [PRIMARY]. Challenges include the need for improved assays to measure antiviral function and mucosal responses. New technologies like single cell analysis and viral inhibition assays provide more detailed immune profiling but require significant bioinformatics support [SECONDARY]. The goal is to define immune correlates of protection to guide vaccine design, but this remains difficult without human challenge models [THIRDARY].
This document discusses using gene and miRNA expression profiling to develop biomarkers for monitoring genotoxicity. It describes:
1. Developing gene-based in vitro biomarkers for genotoxicity using RT2 Profiler PCR Arrays to analyze expression of DNA damage and p53 pathway genes in HepG2 cells exposed to genotoxic and non-genotoxic compounds. 11 genes were identified as classifiers.
2. Identifying miRNA-based in vivo biomarkers by profiling miRNA expression in mouse liver after exposure to the carcinogen ENU using miScript PCR Arrays. The mir-34 family showed temporal changes and clustering analysis identified differentially expressed miRNAs.
3. miRNA profiles have potential to serve as biomarkers for genotoxicity
The document describes a new method called NAIMA-MA (Nucleic Acid Sequence-Based Amplification integrated Multiplex Amplification) that allows for fast, high-throughput and quantitative detection of genetically modified organisms (GMOs). NAIMA-MA uses isothermal amplification to simultaneously amplify multiple DNA targets in a sample in under 25 minutes. The amplified products can then be directly detected on microarrays, providing identification and quantification of GMOs in one step with high sensitivity down to less than 20 DNA copies. The method shows potential for improving current GMO detection techniques by offering higher throughput, lower costs, and simplified workflow compared to quantitative PCR (qPCR).
CIMNA is an immunology service center that offers immune response analysis to support drug development. It provides expertise, state-of-the-art technologies, and quality services through specialized immunology testing including flow cytometry, ELISPOT, bead arrays, and transcriptomics. CIMNA has over 60 employees working in a 1300 square meter facility in Nantes, France, and is overseen by a scientific committee of experts in immunology and therapeutic areas.
2011 course on Molecular Diagnostic Automation - Part 3 - DetectionPatrick Merel
2011 course on Molecular Diagnostic Automation - Part 3 - Detection.
This is from early 2011. Prices and Specifications of instruments may have changed a lot.
Part 3 of 3
Microbial S.L. is a biotechnological company devoted to the design and production of products for the rapid detection of pathogen microorganisms in environmental and food samples.
2011 course on Molecular Diagnostic Automation - Part 2 - AmplificationPatrick Merel
2011 course on Molecular Diagnostic Automation - Part 2 - Amplification.
This is from early 2011. Prices and Specifications of instruments may have changed.
Part 2 of 3
The document discusses immune monitoring in vaccine trials. It provides context on regulatory requirements and the need for standardization. A variety of assays are used to assess cellular and antibody responses, including ELISPOT, flow cytometry, and neutralizing antibody assays [PRIMARY]. Challenges include the need for improved assays to measure antiviral function and mucosal responses. New technologies like single cell analysis and viral inhibition assays provide more detailed immune profiling but require significant bioinformatics support [SECONDARY]. The goal is to define immune correlates of protection to guide vaccine design, but this remains difficult without human challenge models [THIRDARY].
This document discusses using gene and miRNA expression profiling to develop biomarkers for monitoring genotoxicity. It describes:
1. Developing gene-based in vitro biomarkers for genotoxicity using RT2 Profiler PCR Arrays to analyze expression of DNA damage and p53 pathway genes in HepG2 cells exposed to genotoxic and non-genotoxic compounds. 11 genes were identified as classifiers.
2. Identifying miRNA-based in vivo biomarkers by profiling miRNA expression in mouse liver after exposure to the carcinogen ENU using miScript PCR Arrays. The mir-34 family showed temporal changes and clustering analysis identified differentially expressed miRNAs.
3. miRNA profiles have potential to serve as biomarkers for genotoxicity
The document describes a new method called NAIMA-MA (Nucleic Acid Sequence-Based Amplification integrated Multiplex Amplification) that allows for fast, high-throughput and quantitative detection of genetically modified organisms (GMOs). NAIMA-MA uses isothermal amplification to simultaneously amplify multiple DNA targets in a sample in under 25 minutes. The amplified products can then be directly detected on microarrays, providing identification and quantification of GMOs in one step with high sensitivity down to less than 20 DNA copies. The method shows potential for improving current GMO detection techniques by offering higher throughput, lower costs, and simplified workflow compared to quantitative PCR (qPCR).
Does your cell line have a secret? Avoid surprises with characterizationMerck Life Sciences
Watch the recording of this webinar here: https://bit.ly/2Y05bV4
The first step to avoiding an unpleasant and costly contamination event is characterization of your cell banks.
Regardless of the biotech product, careful characterization of the cell banks used in its production is the first step in mitigating the risk of a contamination event. In fact, cell line characterization is an important component of the overall viral safety strategy for the product. We will describe the testing necessary to ensure cell banks are free from infectious and other adverse agents and that meets current regulatory expectations. Different levels of testing are performed for master, working, and end of production cell banks, and the differences in testing for each of these types of banks will be discussed.
In this webinar, you will learn:
• The types of tests that are needed to fully characterize your cell banks
• The best tests to use for your particular cell line
• Reasons why a viral contaminant may be missed
IntOGen, Integrative Oncogenomics for Personal Cancer Genomeschristian.perez
IntOGen was presented September, 11th at the CSHL Meeting on Personal Genomes. The talk was given by Christian Perez-Llamas and he presented the main features of the current version and the advances of IntOGen 2.0 to store, analyze and visualize next generation sequencing data from cancer samples.
CSHL Meeting on Personal Cancer Genomes web: http://meetings.cshl.edu/meetings/person10.shtml
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...Thermo Fisher Scientific
This document describes how digital PCR on the TaqMan OpenArray platform can be used as a sensitive tool for detecting genetically modified organisms (GMOs). [The summary describes:]
1) Custom TaqMan assays were designed to differentiate between GMO and wild-type soybean DNA. 2) The assays were validated for specificity using digital PCR. 3) Spike-in experiments were conducted adding GMO DNA at levels as low as 0.01% to wild-type DNA, and digital PCR accurately measured ratios matching estimated levels.
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3pCCjPF
Ensure your Adeno-Associated Virus (AAV) is safe throughout its entire drug development journey. Learn methods that will help you speed to clinic, potentially treating diseases sooner and with greater effectiveness.
The potential of gene therapies to cure previously untreatable diseases has spurred the development of novel drugs, including those based on Adeno-Associated Virus (AAV). As with all biopharmaceuticals, it is important to identify and monitor the critical quality attributes (CQAs) of these products to ensure their safety and efficacy.
In this webinar, we will present a range of orthogonal methods to understand and define the CQAs of AAV products. These include assays for the confirmation of capsid protein identity and quantity, as well as the characterization of important product-related impurities, such as aggregates. Together these methods represent a comprehensive analytical testing package to support the characterization and lot release of AAV products.
In this webinar, you will learn:
• How to identify and monitor the critical quality attributes (CQAs) of your AAV therapy
• What assays to utilize to confirm capsid protein identity and quantity
• Why you need look to product characterization to identify and remove important product-related impurities
This is a presentation giving an overview of the GeneXpert DX system for detection of MTB. The assay described in this presentation is the MTB/RIF test.
Watch the presentation of this webinar here: https://bit.ly/2SWCycq
mRNA has taken center stage. Vaccines and therapeutics based on this versatile biomolecule have the potential to transform disease prevention and treatment. This webinar will explore key considerations for efficient mRNA production, starting from facility design and raw materials selection to technologies and strategies used for manufacturing.
The success of mRNA-based COVID-19 vaccines has created a significant level of interest in this versatile biomolecule for disease prevention and treatment. While production of these vaccines took place in record time, critical decisions must be made when developing novel mRNA applications to ensure manufacturability, reproducibility, and safety. This webinar will explore foundational elements of the mRNA manufacturing workflow and strategies to design the right facilities to ensure success. Topics include collaborative approaches to ensure access to high quality raw materials, application of advanced technologies for manufacturing, options for facility design and key considerations when leveraging a contract development and manufacturing partner.
In this webinar, you will learn:
• Therapeutic potential of mRNA: COVID-19 and beyond
• How mRNA manufacturing workflows and facility design have a significant impact on reproducibility and performance
• Amptec capabilities to accelerate mRNA development and manufacturing
New technology and workflow for integrated collection, stabilization and puri...QIAGEN
Research into non-invasive prenatal testing (NIPT) and circulating tumor DNA (ctDNA) testing based on circulating cell-free DNA (ccfDNA) is rapidly expanding. However, detection and quantification of ccfDNA is compromised by the release of genomic DNA (gDNA) from lymphocytes due to mechanical lysis or apoptosis during blood collection, storage and transport. PreAnalytiX has developed the PAXgene Blood ccfDNA System, consisting of the PAXgene Blood ccfDNA Tube, a plastic blood collection tube with a unique, non-crosslinking chemistry that preserves extracellular levels of ccfDNA and prevents the release of intracellular DNA from cells into the plasma, and the QIAsymphonyPAXgene Blood ccfDNA Kit for automated ccfDNA extraction from up to 5 ml of plasma. In this slidedeck, this new technology development is presented in comparison to other existing technologies.
Detection and Surveillance of Antibiotic Resistance Genes From Food and Ferti...QIAGEN
One potential way to acquire antibiotic resistance genes is through the food supply chain. Both livestock and feed may
acquire antibiotic resistant bacteria via different mechanisms. Foodstuffs can be exposed to antibiotic resistant bacteria
through fertilizer originating from waste-water treatment plants. This, in addition to increasing administration of antibiotics
to livestock, can lead to food being a potential source of antibiotic resistance genes. This may lead to horizontal gene
transfer to pathogenic enteropathogens and further to drug resistance in humans. Therefore, the surveillance and prevention
of antibiotic resistance genes in food is important.
To effectively combat the spread of difficult-to-treat bacterial infections, rapid surveillance methods to detect antibiotic
resistance genes are required; in order to monitor both bacterial isolates and metagenomic samples.
Since the gut is known to act as a reservoir for antibiotic resistance genes, a small-scale research study was performed on
5 stool samples isolated from healthy human adults using an antibiotic resistance gene identification PCR array. In addition,
the diversity of antibiotic resistance genes in municipal biosolids was determined using an Antibiotic Resistance Genes
Microbial DNA qPCR Array with DNA extracted from belt-filter, press-cake sewage samples.
22 antibiotic resistance genes were identified from different resistance classifications. Further studies were performed in
beef, chicken, vegetable and pork samples. In conclusion, PCR arrays can be effective tools for detection of antibiotic
resistance genes from food samples and potential fertilizer sources.
This document discusses recent updates in the diagnosis of tuberculosis (TB). Direct diagnostic methods discussed include microscopic examination of samples after staining, various culture methods, and nucleic acid amplification tests. Microscopic examination remains the quickest method but has limited sensitivity. Culture allows for identification of the causative organism and is more sensitive but takes longer. Newer rapid culture methods using broth take less time than traditional solid culture. Molecular tests like PCR and LAMP can directly detect TB from samples and provide results faster than culture, but require more validation and quality control.
Pcr technology and its importance in covid 19 pandemicAnupam Maity
Since the discovery of the PCR technology, its application in the various fields is increased gradually. Based on to this principle, many variations of the PCR have been established. Year by year, it is upgraded very much. It is established as a most common and accurate technique for the detection of the various diseases in the field of medicine. Now it is a ‘Gold standard’ for the detection of covid-19 also, which is much needed to contain the spread of the virus. Though various detection techniques are there for detection, but real time RT-PCR (variation of PCR) is most reliable. Viral detection is based on a simple principle of nucleic acid (viral) amplification. Various manufacturing companies are manufacturing the PCR instrument. Though the accuracy of the instruments are slightly differ to each other.
This document discusses molecular diagnosis of tuberculosis through nucleic acid amplification (NAA) methods like polymerase chain reaction (PCR) and transcription mediated amplification (TMA). NAA allows direct detection of mycobacterial DNA or RNA from specimens before culture results. PCR amplifies a specific DNA sequence using primers and DNA polymerase, resulting in exponential multiplication of the target sequence. TMA is an isothermal method that uses RNA transcription and DNA synthesis to amplify nucleic acids. Commercial NAA tests for tuberculosis detection include Amplicor and Enhanced Mycobacterium Tuberculosis Direct test, which have reported sensitivities of 79.4-95.2% and specificities of 98.8-100% compared to culture.
Evaluation of the Roche AMPLICOR® Human Papillomavirus (HPV) Test*Alberto Cuadrado
The Roche AMPLICOR® Human Papillomavirus (HPV) Test* is a PCR-based qualitative assay for the
detection of high-risk human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68
The test permits simultaneous PCR amplification of HPV target DNA within the L1 region of the HPV
genome, and a human DNA marker (β-globin) as a cellular and inhibition control
The amplified products (amplicon) are detected by hybridization to a pool of HPV probes coated on a
single microwell plate well, followed by an enzymatic reaction; detection of the β-globin control is
performed in a separate well
Biosafety in Gene Therapy: Applying the latest regulatory guidance for RCL te...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/33WUiqE
Ensuring the safety and quality of your lentiviral vector is of the utmost importance. Attend this webinar to learn about testing strategies to monitor replication competent lentivirus. You will also hear about recent changes in regulatory guidance with regards to sample types and volumes tested.
The use of lentivirus vectors to produce groundbreaking gene therapies is on the rise. Ensuring the biosafety and quality of these vectors is achieved through a multi-tiered testing approach.
For lentivirus-based therapies, generation of replication competent particles is a potential risk. While improvements in design and manufacturing have decreased the probability of producing replication competent viruses, regulatory agencies provide guidelines to test for their presence at multiple stages in production. This webinar reviews the strategies for monitoring replication competent lentiviruses. We describe current methods and address: Sample types, testing volumes, and expected results.
In this webinar, you will learn about:
• The latest FDA regulatory guidelines on replication competent lentivirus (RCL) testing
• Methods used to monitor RCL
• Considerations on sample type and volume requirements
Biosafety testing of gm crops icar november 29 2011Tulika Singh
Biosafety tests are conducted on GM crops to identify and manage risks to humans, animals, and the environment. The approval process in India involves extensive safety assessment and confined field trials before limited commercialization. Biosafety research trials (BRL1 and BRL2) of up to 3 years are required and regulated by RCGM and GEAC. They have defined limits on trial size, locations, isolation distances, and composition to safely evaluate GM crop performance while mitigating establishment and spread. The process aims to scientifically assess risks and benefits to recommend environmentally safe transgenic crops for commercial use.
This document discusses new technologies for the diagnosis of tuberculosis. It describes how microscopy using light emitting diodes has advanced diagnosis by providing a simple, robust method. Molecular tests like PCR and line probe assays can rapidly detect TB and drug resistance from samples, but are more expensive and complex. The WHO endorses tests like Xpert MTB/RIF that can simultaneously detect TB and rifampicin resistance in a few hours. While promising, molecular methods still have limitations around cost, availability, and cannot replace clinical assessment.
This document provides an overview of the history and methods of microbial identification. It discusses how identification methods have evolved from using tubed and plated media in the 1960s to now using miniaturized biochemical reactions and system-dependent approaches comparing reaction patterns to databases. Modern rapid identification approaches include varying conventional testing, unique substrates that detect activity without growth, antigen-antibody reactions, and molecular detection methods. Specific techniques like colorimetry, fluorescence, and turbidity are used to detect metabolic activity. Rapid tests for identifying common bacteria like Staphylococcus aureus and Streptococcus pyogenes using agglutination, chromogenic media, DNA probes, PCR, and immunochromatographic assays are also overviewed.
This document discusses techniques for detecting and identifying plant viruses in quarantine. It covers:
1. An overview of plant viruses, their characteristics and modes of transmission.
2. Various detection techniques including biological, physical, biochemical, serological and molecular methods. Serological techniques include ELISA and molecular methods include PCR, RT-PCR and real-time PCR.
3. Details on techniques like mechanical inoculation, electron microscopy, and nucleic acid-based methods.
4. The use of these techniques to detect and identify important quarantine viruses.
Technical Guide to Qiagen PCR Arrays - Download the GuideQIAGEN
Total RNA discovery with RT2 and miScript PCR Arrays : Explore the RNA universe - Whatever your destination within the RNA universe, QIAGEN will help you get there. The miRNeasy kits deliver pure, high-quality total RNA from a broad range of samples. The RT2 and miScript PCR arrays are a complete solution both for focused analysis of gene and microRNA expression and for validation of microarray and RNA sequencing experiments. Together with the powerful analytics tools of GeneGlobe® and QIAGEN Ingenuity® Pathway Analysis, these products give you a smooth path from your sample to high-quality results.
This document discusses practical approaches for diagnosing viral diseases in poultry, including clinical diagnosis, rapid field diagnostic tests, serological diagnosis, molecular diagnosis, and isolation/characterization. Clinical diagnosis is based on case history, clinical signs, examination of live/dead birds, and gross lesions. Rapid field tests can detect viruses but require high viral titers. Serological tests detect antibodies but have delays. Molecular diagnosis using PCR technologies can sensitively and specifically detect pathogens. The document emphasizes that clinical signs alone are not confirmatory and that multiple diagnostic approaches should be used to accurately diagnose poultry viral diseases.
Microarrays allow researchers to examine gene expression patterns across thousands of genes simultaneously. A microarray contains probes for known genes that are used to detect complementary mRNA in a biological sample. Microarrays can be used to study gene expression differences between normal and diseased tissues, classify tumor subtypes, and diagnose cancers. They also show promise for personalized cancer treatment by predicting patient prognosis and response to therapy.
Does your cell line have a secret? Avoid surprises with characterizationMerck Life Sciences
Watch the recording of this webinar here: https://bit.ly/2Y05bV4
The first step to avoiding an unpleasant and costly contamination event is characterization of your cell banks.
Regardless of the biotech product, careful characterization of the cell banks used in its production is the first step in mitigating the risk of a contamination event. In fact, cell line characterization is an important component of the overall viral safety strategy for the product. We will describe the testing necessary to ensure cell banks are free from infectious and other adverse agents and that meets current regulatory expectations. Different levels of testing are performed for master, working, and end of production cell banks, and the differences in testing for each of these types of banks will be discussed.
In this webinar, you will learn:
• The types of tests that are needed to fully characterize your cell banks
• The best tests to use for your particular cell line
• Reasons why a viral contaminant may be missed
IntOGen, Integrative Oncogenomics for Personal Cancer Genomeschristian.perez
IntOGen was presented September, 11th at the CSHL Meeting on Personal Genomes. The talk was given by Christian Perez-Llamas and he presented the main features of the current version and the advances of IntOGen 2.0 to store, analyze and visualize next generation sequencing data from cancer samples.
CSHL Meeting on Personal Cancer Genomes web: http://meetings.cshl.edu/meetings/person10.shtml
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...Thermo Fisher Scientific
This document describes how digital PCR on the TaqMan OpenArray platform can be used as a sensitive tool for detecting genetically modified organisms (GMOs). [The summary describes:]
1) Custom TaqMan assays were designed to differentiate between GMO and wild-type soybean DNA. 2) The assays were validated for specificity using digital PCR. 3) Spike-in experiments were conducted adding GMO DNA at levels as low as 0.01% to wild-type DNA, and digital PCR accurately measured ratios matching estimated levels.
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3pCCjPF
Ensure your Adeno-Associated Virus (AAV) is safe throughout its entire drug development journey. Learn methods that will help you speed to clinic, potentially treating diseases sooner and with greater effectiveness.
The potential of gene therapies to cure previously untreatable diseases has spurred the development of novel drugs, including those based on Adeno-Associated Virus (AAV). As with all biopharmaceuticals, it is important to identify and monitor the critical quality attributes (CQAs) of these products to ensure their safety and efficacy.
In this webinar, we will present a range of orthogonal methods to understand and define the CQAs of AAV products. These include assays for the confirmation of capsid protein identity and quantity, as well as the characterization of important product-related impurities, such as aggregates. Together these methods represent a comprehensive analytical testing package to support the characterization and lot release of AAV products.
In this webinar, you will learn:
• How to identify and monitor the critical quality attributes (CQAs) of your AAV therapy
• What assays to utilize to confirm capsid protein identity and quantity
• Why you need look to product characterization to identify and remove important product-related impurities
This is a presentation giving an overview of the GeneXpert DX system for detection of MTB. The assay described in this presentation is the MTB/RIF test.
Watch the presentation of this webinar here: https://bit.ly/2SWCycq
mRNA has taken center stage. Vaccines and therapeutics based on this versatile biomolecule have the potential to transform disease prevention and treatment. This webinar will explore key considerations for efficient mRNA production, starting from facility design and raw materials selection to technologies and strategies used for manufacturing.
The success of mRNA-based COVID-19 vaccines has created a significant level of interest in this versatile biomolecule for disease prevention and treatment. While production of these vaccines took place in record time, critical decisions must be made when developing novel mRNA applications to ensure manufacturability, reproducibility, and safety. This webinar will explore foundational elements of the mRNA manufacturing workflow and strategies to design the right facilities to ensure success. Topics include collaborative approaches to ensure access to high quality raw materials, application of advanced technologies for manufacturing, options for facility design and key considerations when leveraging a contract development and manufacturing partner.
In this webinar, you will learn:
• Therapeutic potential of mRNA: COVID-19 and beyond
• How mRNA manufacturing workflows and facility design have a significant impact on reproducibility and performance
• Amptec capabilities to accelerate mRNA development and manufacturing
New technology and workflow for integrated collection, stabilization and puri...QIAGEN
Research into non-invasive prenatal testing (NIPT) and circulating tumor DNA (ctDNA) testing based on circulating cell-free DNA (ccfDNA) is rapidly expanding. However, detection and quantification of ccfDNA is compromised by the release of genomic DNA (gDNA) from lymphocytes due to mechanical lysis or apoptosis during blood collection, storage and transport. PreAnalytiX has developed the PAXgene Blood ccfDNA System, consisting of the PAXgene Blood ccfDNA Tube, a plastic blood collection tube with a unique, non-crosslinking chemistry that preserves extracellular levels of ccfDNA and prevents the release of intracellular DNA from cells into the plasma, and the QIAsymphonyPAXgene Blood ccfDNA Kit for automated ccfDNA extraction from up to 5 ml of plasma. In this slidedeck, this new technology development is presented in comparison to other existing technologies.
Detection and Surveillance of Antibiotic Resistance Genes From Food and Ferti...QIAGEN
One potential way to acquire antibiotic resistance genes is through the food supply chain. Both livestock and feed may
acquire antibiotic resistant bacteria via different mechanisms. Foodstuffs can be exposed to antibiotic resistant bacteria
through fertilizer originating from waste-water treatment plants. This, in addition to increasing administration of antibiotics
to livestock, can lead to food being a potential source of antibiotic resistance genes. This may lead to horizontal gene
transfer to pathogenic enteropathogens and further to drug resistance in humans. Therefore, the surveillance and prevention
of antibiotic resistance genes in food is important.
To effectively combat the spread of difficult-to-treat bacterial infections, rapid surveillance methods to detect antibiotic
resistance genes are required; in order to monitor both bacterial isolates and metagenomic samples.
Since the gut is known to act as a reservoir for antibiotic resistance genes, a small-scale research study was performed on
5 stool samples isolated from healthy human adults using an antibiotic resistance gene identification PCR array. In addition,
the diversity of antibiotic resistance genes in municipal biosolids was determined using an Antibiotic Resistance Genes
Microbial DNA qPCR Array with DNA extracted from belt-filter, press-cake sewage samples.
22 antibiotic resistance genes were identified from different resistance classifications. Further studies were performed in
beef, chicken, vegetable and pork samples. In conclusion, PCR arrays can be effective tools for detection of antibiotic
resistance genes from food samples and potential fertilizer sources.
This document discusses recent updates in the diagnosis of tuberculosis (TB). Direct diagnostic methods discussed include microscopic examination of samples after staining, various culture methods, and nucleic acid amplification tests. Microscopic examination remains the quickest method but has limited sensitivity. Culture allows for identification of the causative organism and is more sensitive but takes longer. Newer rapid culture methods using broth take less time than traditional solid culture. Molecular tests like PCR and LAMP can directly detect TB from samples and provide results faster than culture, but require more validation and quality control.
Pcr technology and its importance in covid 19 pandemicAnupam Maity
Since the discovery of the PCR technology, its application in the various fields is increased gradually. Based on to this principle, many variations of the PCR have been established. Year by year, it is upgraded very much. It is established as a most common and accurate technique for the detection of the various diseases in the field of medicine. Now it is a ‘Gold standard’ for the detection of covid-19 also, which is much needed to contain the spread of the virus. Though various detection techniques are there for detection, but real time RT-PCR (variation of PCR) is most reliable. Viral detection is based on a simple principle of nucleic acid (viral) amplification. Various manufacturing companies are manufacturing the PCR instrument. Though the accuracy of the instruments are slightly differ to each other.
This document discusses molecular diagnosis of tuberculosis through nucleic acid amplification (NAA) methods like polymerase chain reaction (PCR) and transcription mediated amplification (TMA). NAA allows direct detection of mycobacterial DNA or RNA from specimens before culture results. PCR amplifies a specific DNA sequence using primers and DNA polymerase, resulting in exponential multiplication of the target sequence. TMA is an isothermal method that uses RNA transcription and DNA synthesis to amplify nucleic acids. Commercial NAA tests for tuberculosis detection include Amplicor and Enhanced Mycobacterium Tuberculosis Direct test, which have reported sensitivities of 79.4-95.2% and specificities of 98.8-100% compared to culture.
Evaluation of the Roche AMPLICOR® Human Papillomavirus (HPV) Test*Alberto Cuadrado
The Roche AMPLICOR® Human Papillomavirus (HPV) Test* is a PCR-based qualitative assay for the
detection of high-risk human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68
The test permits simultaneous PCR amplification of HPV target DNA within the L1 region of the HPV
genome, and a human DNA marker (β-globin) as a cellular and inhibition control
The amplified products (amplicon) are detected by hybridization to a pool of HPV probes coated on a
single microwell plate well, followed by an enzymatic reaction; detection of the β-globin control is
performed in a separate well
Biosafety in Gene Therapy: Applying the latest regulatory guidance for RCL te...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/33WUiqE
Ensuring the safety and quality of your lentiviral vector is of the utmost importance. Attend this webinar to learn about testing strategies to monitor replication competent lentivirus. You will also hear about recent changes in regulatory guidance with regards to sample types and volumes tested.
The use of lentivirus vectors to produce groundbreaking gene therapies is on the rise. Ensuring the biosafety and quality of these vectors is achieved through a multi-tiered testing approach.
For lentivirus-based therapies, generation of replication competent particles is a potential risk. While improvements in design and manufacturing have decreased the probability of producing replication competent viruses, regulatory agencies provide guidelines to test for their presence at multiple stages in production. This webinar reviews the strategies for monitoring replication competent lentiviruses. We describe current methods and address: Sample types, testing volumes, and expected results.
In this webinar, you will learn about:
• The latest FDA regulatory guidelines on replication competent lentivirus (RCL) testing
• Methods used to monitor RCL
• Considerations on sample type and volume requirements
Biosafety testing of gm crops icar november 29 2011Tulika Singh
Biosafety tests are conducted on GM crops to identify and manage risks to humans, animals, and the environment. The approval process in India involves extensive safety assessment and confined field trials before limited commercialization. Biosafety research trials (BRL1 and BRL2) of up to 3 years are required and regulated by RCGM and GEAC. They have defined limits on trial size, locations, isolation distances, and composition to safely evaluate GM crop performance while mitigating establishment and spread. The process aims to scientifically assess risks and benefits to recommend environmentally safe transgenic crops for commercial use.
This document discusses new technologies for the diagnosis of tuberculosis. It describes how microscopy using light emitting diodes has advanced diagnosis by providing a simple, robust method. Molecular tests like PCR and line probe assays can rapidly detect TB and drug resistance from samples, but are more expensive and complex. The WHO endorses tests like Xpert MTB/RIF that can simultaneously detect TB and rifampicin resistance in a few hours. While promising, molecular methods still have limitations around cost, availability, and cannot replace clinical assessment.
This document provides an overview of the history and methods of microbial identification. It discusses how identification methods have evolved from using tubed and plated media in the 1960s to now using miniaturized biochemical reactions and system-dependent approaches comparing reaction patterns to databases. Modern rapid identification approaches include varying conventional testing, unique substrates that detect activity without growth, antigen-antibody reactions, and molecular detection methods. Specific techniques like colorimetry, fluorescence, and turbidity are used to detect metabolic activity. Rapid tests for identifying common bacteria like Staphylococcus aureus and Streptococcus pyogenes using agglutination, chromogenic media, DNA probes, PCR, and immunochromatographic assays are also overviewed.
This document discusses techniques for detecting and identifying plant viruses in quarantine. It covers:
1. An overview of plant viruses, their characteristics and modes of transmission.
2. Various detection techniques including biological, physical, biochemical, serological and molecular methods. Serological techniques include ELISA and molecular methods include PCR, RT-PCR and real-time PCR.
3. Details on techniques like mechanical inoculation, electron microscopy, and nucleic acid-based methods.
4. The use of these techniques to detect and identify important quarantine viruses.
Technical Guide to Qiagen PCR Arrays - Download the GuideQIAGEN
Total RNA discovery with RT2 and miScript PCR Arrays : Explore the RNA universe - Whatever your destination within the RNA universe, QIAGEN will help you get there. The miRNeasy kits deliver pure, high-quality total RNA from a broad range of samples. The RT2 and miScript PCR arrays are a complete solution both for focused analysis of gene and microRNA expression and for validation of microarray and RNA sequencing experiments. Together with the powerful analytics tools of GeneGlobe® and QIAGEN Ingenuity® Pathway Analysis, these products give you a smooth path from your sample to high-quality results.
This document discusses practical approaches for diagnosing viral diseases in poultry, including clinical diagnosis, rapid field diagnostic tests, serological diagnosis, molecular diagnosis, and isolation/characterization. Clinical diagnosis is based on case history, clinical signs, examination of live/dead birds, and gross lesions. Rapid field tests can detect viruses but require high viral titers. Serological tests detect antibodies but have delays. Molecular diagnosis using PCR technologies can sensitively and specifically detect pathogens. The document emphasizes that clinical signs alone are not confirmatory and that multiple diagnostic approaches should be used to accurately diagnose poultry viral diseases.
Microarrays allow researchers to examine gene expression patterns across thousands of genes simultaneously. A microarray contains probes for known genes that are used to detect complementary mRNA in a biological sample. Microarrays can be used to study gene expression differences between normal and diseased tissues, classify tumor subtypes, and diagnose cancers. They also show promise for personalized cancer treatment by predicting patient prognosis and response to therapy.
This document provides information on the diagnosis and management of tuberculosis (TB) under the Revised National Tuberculosis Control Program (RNTCP) in India. It discusses the diagnostic approaches for pulmonary and extra-pulmonary TB including symptoms, bacteriological methods like smear microscopy and culture, histopathological examination, radiological imaging, and serological and biochemical markers. It also describes various rapid diagnostic tests like nucleic acid amplification tests, line probe assays, and the Xpert MTB/RIF test. The document outlines the laboratory methods for diagnosis including solid and liquid culture and discusses new techniques like molecular diagnosis. It highlights the components of DOTS strategy implemented under the RNTCP for effective TB management in India.
This document describes the Intelligent Integrated Systems for Personalized Medicine (ISyPeM) project. The project aims to develop a platform for computer-assisted real-time dose adjustment of long-term drug therapies through personalized medicine approaches. In the short term, the project will focus on HIV therapies, immunosuppression for organ transplants, and anticancer therapies. The platform will integrate biosensors, algorithms, and low-power electronics to provide automated drug monitoring and delivery.
miRNA Seq
Dr. Sikandar Hayat Khan discusses miRNA sequencing (miRNA Seq) and its emerging role in medical sciences. He summarizes the process of miRNA Seq which includes miRNA sampling, extraction, cDNA library preparation, sequencing, and bioinformatics analysis. miRNA Seq can provide a wholesome approach for identifying novel miRNA biomarkers for disease and enable prediction of diseases. However, appropriate methodology selection and interpretation of miRNA data requires bioinformatics knowledge.
Recent Advances in Immune Monitoring Presentation Slides Covance
The human immune system plays a pivotal role in conferring protective immunity to pathogenic microorganisms and cancer while its hyper-activation can result in serious inflammatory conditions such as autoimmunity. Immune monitoring is critical to determine the efficacy of therapeutic approaches such as the administration of a vaccine or to ascertain the safety of an administered agent such as a biologic that targets the immune system. Immune monitoring can involve the measurement of soluble immune mediators including cytokines and chemokines, as well as the analysis of phenotypic and functional status of immune cells. There is a plethora of platforms that offer highly sensitive and specific assays to monitor the immune system. These include simple immunoassays to complex multiplex assays that measure soluble biomarkers in various biological fluids and cell-based assays using a variety of platforms such as flow cytometry and enzyme-linked immunospot (ELISPOT) assay. In order to generate reliable immune monitoring data that will help us determine the safety and efficacy of the therapeutic intervention approach from a global study, highly standardized methods to collect, process and prepare patient samples need to be implemented. These slides focus on the recent advances in immune monitoring.
Plasmid Manufacturing Service from GenScript ProBioGenScript ProBio
GenScript ProBio offers the best Plasmid Manufacturing Service and employs a GMP-compliant plasmid production process that allows customers to replicate DNA used in experiments with minimal additional effort. By employing this process, Genscript can provide plasmids produced at the highest quality standards. For more information, visit our website. https://www.genscriptprobio.com/gct-proplasmid.html
This PPT is about immune system and immune therapy, some basic knowledge about Chimeric Antigen Receptor or CAR technology and its application on tumor therapy.
This document summarizes tools and techniques for studying the innate immune system. It describes the differences between innate and adaptive immunity, the phases and cellular components of the innate response, pattern recognition receptors, signaling pathways, and technologies for research including PCR arrays and reporter assays. An example is given of using a PCR array to study the role of TLR3 in the response to Chlamydia infection, finding that TLR3 and IFN-β are major mediators. Another example shows using a reporter array to identify NF-κB and other pathways activated by cytokine stimulation.
This document describes a digital reconstruction method called DigiWest that allows high-throughput analysis of Western blots. DigiWest separates proteins by molecular weight, cuts the membrane into strips, and elutes the proteins to couple them to color-coded Luminex beads. This allows multiplexed analysis using standard antibodies. The method was tested on liver tissue to analyze signaling pathways with higher sensitivity than traditional Western blots and allowed analysis of over 1,000 lanes of a kinase panel to study lapatinib resistance. DigiWest provides a quantitative digital output and increased throughput for protein signaling analysis.
This document discusses the history and developments in genetic therapy. It covers:
- Early discussions on ethics and potential applications in the 1960s-1970s
- The first clinical trials in the 1980s-1990s testing various viral vectors and gene delivery methods
- Setbacks like the death of a patient in 1999 from organ failure after a gene therapy trial
- Successes of gene therapy programs for severe combined immunodeficiency (SCID) in the 2000s
- Advances in delivery methods like crossing the blood-brain barrier in 2003 and use of miRNAs in 2006
- The first gene therapy approved for an inherited retinal disease in 2007
Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...Thermo Fisher Scientific
1) The document describes a multiplex next-generation sequencing assay that can detect somatic mutations at a frequency of 0.5% from circulating tumor cells (CTC) and cell-free tumor DNA (ctDNA) obtained from a single blood sample.
2) A research workflow is presented that isolates white blood cells, plasma DNA, and CTCs from blood samples, prepares barcoded libraries from each fraction, and sequences them on an Ion chip to enable detection of low frequency variants down to 0.5% using statistical modeling and filtering.
3) The assay requires only 10ng of input DNA, has a turnaround time of less than 24 hours, and demonstrates the ability to accurately detect somatic mutations at
Dr. Richard Cote of Sylvester Comprehensive Cancer Center presented "New Technologies That Will Have an Impact on Cancer" at the 2011 WellBeingWell Conference in Miami.
This document summarizes Michael Buschmann's work on nanomedicine at Ecole Polytechnique. It discusses how nanomedicine uses nano-sized tools for diagnosis, prevention and treatment of disease. Some key applications of nanomedicine include drug delivery via liposomes and polymeric nanoparticles. The document also outlines the requirements for successful nanomedicine research and development, including efficacy, safety, manufacturing and regulatory approval. Buschmann's group works on developing chitosan-based nanoparticles for gene delivery applications.
The Center of Excellence in Cancer Research (CECR) was established in June 2013 at Tanta University Educational Hospital in Egypt. It is directed by Dr. Mohamed L. Salem and focuses on correlating immunologic and clinical data from genomic, transcriptomic, and proteomic profiling of circulating and primary tumor cells. The CECR has facilities for flow cytometry, cell sorting, microarrays, and Luminex technology. Its research team studies cancer immunology and diagnosis.
Epiontis immune monitoring and companion diagnostics 2013TOKBSL
Epiontis introduces novel epigenetic immune cell markers that enable standardized immune monitoring from frozen whole blood or tissue samples. The markers allow precise quantification of immune cells using quantitative PCR targeting cell type-specific epigenetic modifications. The assays require small sample volumes and can measure a wide range of immune cell types from various sample types and storage conditions. Epiontis has extensive experience and quality management systems for clinical trial immune monitoring.
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...APCO
The Radar reflects input from APCO’s teams located around the world. It distils a host of interconnected events and trends into insights to inform operational and strategic decisions. Issues covered in this edition include:
Easily Verify Compliance and Security with Binance KYCAny kyc Account
Use our simple KYC verification guide to make sure your Binance account is safe and compliant. Discover the fundamentals, appreciate the significance of KYC, and trade on one of the biggest cryptocurrency exchanges with confidence.
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesHolger Mueller
Holger Mueller of Constellation Research shares his key takeaways from SAP's Sapphire confernece, held in Orlando, June 3rd till 5th 2024, in the Orange Convention Center.
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...Aleksey Savkin
The Strategy Implementation System offers a structured approach to translating stakeholder needs into actionable strategies using high-level and low-level scorecards. It involves stakeholder analysis, strategy decomposition, adoption of strategic frameworks like Balanced Scorecard or OKR, and alignment of goals, initiatives, and KPIs.
Key Components:
- Stakeholder Analysis
- Strategy Decomposition
- Adoption of Business Frameworks
- Goal Setting
- Initiatives and Action Plans
- KPIs and Performance Metrics
- Learning and Adaptation
- Alignment and Cascading of Scorecards
Benefits:
- Systematic strategy formulation and execution.
- Framework flexibility and automation.
- Enhanced alignment and strategic focus across the organization.
Discover timeless style with the 2022 Vintage Roman Numerals Men's Ring. Crafted from premium stainless steel, this 6mm wide ring embodies elegance and durability. Perfect as a gift, it seamlessly blends classic Roman numeral detailing with modern sophistication, making it an ideal accessory for any occasion.
https://rb.gy/usj1a2
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...my Pandit
Dive into the steadfast world of the Taurus Zodiac Sign. Discover the grounded, stable, and logical nature of Taurus individuals, and explore their key personality traits, important dates, and horoscope insights. Learn how the determination and patience of the Taurus sign make them the rock-steady achievers and anchors of the zodiac.
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This PowerPoint compilation offers a comprehensive overview of 20 leading innovation management frameworks and methodologies, selected for their broad applicability across various industries and organizational contexts. These frameworks are valuable resources for a wide range of users, including business professionals, educators, and consultants.
Each framework is presented with visually engaging diagrams and templates, ensuring the content is both informative and appealing. While this compilation is thorough, please note that the slides are intended as supplementary resources and may not be sufficient for standalone instructional purposes.
This compilation is ideal for anyone looking to enhance their understanding of innovation management and drive meaningful change within their organization. Whether you aim to improve product development processes, enhance customer experiences, or drive digital transformation, these frameworks offer valuable insights and tools to help you achieve your goals.
INCLUDED FRAMEWORKS/MODELS:
1. Stanford’s Design Thinking
2. IDEO’s Human-Centered Design
3. Strategyzer’s Business Model Innovation
4. Lean Startup Methodology
5. Agile Innovation Framework
6. Doblin’s Ten Types of Innovation
7. McKinsey’s Three Horizons of Growth
8. Customer Journey Map
9. Christensen’s Disruptive Innovation Theory
10. Blue Ocean Strategy
11. Strategyn’s Jobs-To-Be-Done (JTBD) Framework with Job Map
12. Design Sprint Framework
13. The Double Diamond
14. Lean Six Sigma DMAIC
15. TRIZ Problem-Solving Framework
16. Edward de Bono’s Six Thinking Hats
17. Stage-Gate Model
18. Toyota’s Six Steps of Kaizen
19. Microsoft’s Digital Transformation Framework
20. Design for Six Sigma (DFSS)
To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations
Innovation Management Frameworks: Your Guide to Creativity & Innovation
CIMNA CRO Central Lab
1. The unique immune
monitoring service
center for your drug
development
www.cimna.org
2. CIMNA Objectives
Why perform immuno monitoring analyses in early clinical
developments ?
Regulatory environment
New requirements of EMEA and FDA for a better understanding of:
• drug mechanisms of action
• scientific context
• initial drug dose evaluation
Industrial environment
• Obtain necessary information for GO/NO GO decisions
• Strategic discovery of Biomarkers
Immune response analysis is a real added value
to strengthen your pipeline
3. A unique integrated Immunomonitoring center
CIMNA is a niche service provider specialized in immunology
CIMNA associates industrial & academic partner to ensure a
high-quality one-stop shop:
EXPERTISE
State of the Art Technologies
QUALITY Services
Project Management
4. CIMNA PARTNERS
TcLand-Expression Atlanstat
Global Management Regulatory affairs
Bio-informatic & biostatistics Clinical operations
Data Management
T cell repertoire units
Statistics
Biomarkers & companion diagnostic
Immunology Laboratory Transcriptomic Platform
Nantes university Hospital Biogen Ouest
Elispot Transcriptomic unit
Flow-cytometry
Multiplex assays Genomic
Elisa Biostatistics
6. Scientific Committee
A high-level scientific committee ensuring best adequacy and
interpretation of information for the specific needs of our
partners
Chairman: Prof. Régis JOSIEN
TECHNOLOGY EXPERTS
• Cytomics: Dr. Marie RIMBERT
• Transcriptomics : Dr. Rémi HOULGATTE
• Repertoire: Dr. Marina GUILLET
• Statistics: Dr. Nadine GODFROID
EXPERTS BY THERAPEUTIC AREA
• Transplantation: Prof. Jean-Paul SOULILLOU
• Autoimmunity/inflammation: Prof. Mohamed HAMIDOU
• Oncology & Immunotherapy: Prof. Marc BONNEVILLE
• Neuroimmunology: Dr. David LAPLAUD
• Allergy: Prof. Antoine MAGNAN
7. Sample management
GBEA
PBMC preparation (Ficoll, up to 50ml)
PBMC freezing / thawing
Cell counting
Cell storage in liquid nitrogen
Serum storage at -80°C
CYTOMIC UNIT
Working according SOP
Well experienced technicians / Hospital Lab
8. ELISPOT
GBEA
antigen-specific cytokine-secreting T cells
antigen-specific CTL
antigen-specific antibody producing B cells
Applications:
Vaccine development
Autoimmunity
CYTOMIC UNIT
Infectious disease
Cancer
Transplantation…
9. Flow Cytometry
GBEA
immune cells (T, B, NK, DC, Mono.)
T cell subsets (naive, effector, central memory, effector
memory)
Counting of antigen-specific T cells with tetramers
Intracellular cytokine staining to assess T cell function
4 cytometers / up to 12 colors:
BD Canto I
CYTOMIC UNIT
BD Canto II
BD FACS Aria Cell sorter
BD LSR II
10. Luminex, ELISA
GBEA
Multiplex bead array assays
Multiple cytokine/chemokine quantification (immune
response, inflammation, cytokine storm, etc..).
Multiple auto-antibody titration
ELISA
Cytokine/chemokine dosage
Immunoglobulin dosage
CYTOMIC UNIT
Auto-antibody detection and titration
Development of custom assays
11. Repertoire Analysis
TcLandScape
Analysis of T cell receptor populations
Transcriptomic approach
REPERTOIRE UNIT
Qualitative analysis of the TCR Vb Gene usage and CDR3 Length distribution
combined with qPCR on TCR mRNA transcripts
12. TcLandScape Indications
Immune response characterization
Targeting immune populations for functional analyses
Effects of drug candidates on T cell mobilization
Epitope spreading
Clonality testing
animal models
REPERTOIRE UNIT
13. ISO qPCR unit
17025
Customized service using our real-time PCR platform (ABI
7900HT)
ISO 17025 compliant
Easy and rapid transfer of your protocol to ISO 17025
REPERTOIRE UNIT
14. ISO
Pangenomic Microarrays services
9001
Agilent Multiplex Gene Expression Microarrays
Human or Mouse, 41 000 Transcripts, 44 000 probes / 60-mers
Affymetrix Genechip Human Genome U133 Plus 2.0
Human, 47 000 Transcripts, 54 000 probes / 25-mers
TRANSCRITOMIC UNIT
15. ISO
Other Microarrays
9001
miRNA expression microarrays
866 human miRNA + 89 viral miRNA, 15 000 probes / 60-mers
SNP genotyping
BioInformatics & biostatistics (21CFR part11)
TRANSCRITOMIC UNIT
16. Clinical operations, Medical Writing
GCP
Identification of medical leaders/experts
Selection of investigators sites
Regulations management
Study Site follow-up
CLINICAL OPERATION UNIT
Project global management
clinical study protocols & reports writing
17. Data Management, Biostatistics
GCP
Data base set up, imports, exports, lock, transfers
Medical data coding
Final quality control, data entry audits, blind data review
Statistical analysis programming
CLINICAL OPERATION UNIT
Full validation and quality control of results
Clinical Study Reports (ICH)